Cost of Alzheimer's Disease and Related Dementia in Managed‐Medicare

BACKGROUND: Managed care organizations (MCOs) will have increased responsibility for the care of large numbers of persons with dementia. There are, however, few studies that inform about decisions of healthcare utilization and expenditures for individuals with dementia in managed care.

[1]  C. Boult,et al.  Identification and assessment of high-risk seniors , 1998 .

[2]  E. Wagner.  The Promise and Performance of HMOS in Improving Outcomes in Older Adults * , 1996, Journal of the American Geriatrics Society.

[3]  M. Von Korff,et al.  Chronic care costs in managed care. , 1997, Health affairs.

[4]  H. Fillit,et al.  How the principles of geriatric assessment are shaping managed care. , 1998, Geriatrics.

[5]  H. Fillit,et al.  The Effect of Dementia on Acute Care in a Geriatric Medical Unit , 1992, International Psychogeriatrics.

[6]  T. Hu,et al.  The economic cost of senile dementia in the United States, 1985. , 1988, Public health reports.

[7]  C. Cox,et al.  Discharge planning for dementia patients: factors influencing caregiver decisions and satisfaction. , 1996, Health & social work.

[8]  R. Mayeux,et al.  Risk of dementia after stroke in a hospitalized cohort , 1994, Neurology.

[9]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.

[10]  D. Knopman,et al.  Opportunities for improving managed care for individuals with dementia: Part 1--The issues. , 1999, The American journal of managed care.

[11]  B. Winblad,et al.  Costs of dementia and dementia care: a review , 1997, International journal of geriatric psychiatry.

[12]  J. Hammer,et al.  Impact of psychiatric comorbidity on length of hospital stay for medical/surgical patients: a preliminary report. , 1987, The American journal of psychiatry.

[13]  J. Robine,et al.  The relationship between age and the prevalence of senile dementia: a meta-analysis of recent data. , 1992, International journal of epidemiology.

[14]  R. Deyo,et al.  Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. , 1992, Journal of clinical epidemiology.

[15]  R. Ernst,et al.  The US economic and social costs of Alzheimer's disease revisited. , 1994, American journal of public health.

[16]  Hu Tw,et al.  The economic cost of senile dementia in the United States, 1985. , 1988 .

[17]  K. Brummel-smith,et al.  GERIATRICS IN MANAGED CARE * : Essential Components of Geriatric Care Provided Through Health Maintenance Organizations The HMO Workgroup on Care Management , 1998, Journal of the American Geriatrics Society.

[18]  H. Allen.  Practice Guideline for the Treatment of Patients with Alzheimer's Disease and other Dementias of Late Life. Edited by American Psychiatric Association. American Psychiatric Association, £17.95. , 2001 .

[19]  J. Cummings,et al.  The economic cost of Alzheimer's disease and related dementias to the California Medicaid program ("Medi-Cal") in 1995. , 1999, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[20]  N. Powe,et al.  Alzheimer's Disease Under Managed Care: Implications from Medicare Utilization and Expenditure Patterns , 1998, Journal of the American Geriatrics Society.

[21]  C. Boult,et al.  GERIATRICS IN MANAGED CARE: Systems of Care for Older Populations of the Future , 1998, Journal of the American Geriatrics Society.

[22]  K. Langwell,et al.  The surge in Medicare managed care: an update. , 1997, Health affairs.